Locations:
Search IconSearch

Neurosciences

18-NEU-986-Cancer stem cells-650×450

Kinase Inhibitor Ibrutinib Shows Preclinical Promise in Glioblastoma

Established lymphoma/leukemia therapy also targets glioma stem cells

17-NEU-551-Cummings-589583890-650×450

Neurodegenerative Diseases at a Crossroads: More Research Funding, or More Nursing Homes?

Cleveland Clinic researchers make the case for investigative urgency

18-NEU-900-DBS-with-TMS-650×450

Another First from a Historic Trial: Novel Pairing of Cerebellar DBS with TMS

Study of DBS for stroke recovery charts new territory in TMS use

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-NEU-1184-DBS-Stroke-650×450

NIH Award Bolsters Cleveland Clinic Investigations of DBS for Stroke Rehabilitation

Will support preclinical work in parallel with ongoing human trial

18-ORT-1087_Styron-Hero-Image-650x450pxl
May 10, 2018/Neurosciences

Acute Flaccid Myelitis: A Modern-day Polio?

In otherwise healthy children, devastating and permanent paralysis can occur

18-NEU-918-Bermel-AAN-650×450

5 Things That Struck Me at the AAN’s 2018 Annual Meeting

From gene therapy for SMA to headache advances, big things are afoot in our field

18-NEU-781-Recinos-Epigenetic-Targeting-650×450
May 7, 2018/Cancer

Epigenetic Targeting: A New Avenue in the Fight Against Pediatric High-Grade Glioma

An array of investigations underway at Cleveland Clinic

opioids&pregnancy_650x450
May 4, 2018/Neurosciences

Managing Addiction and Drug Abuse in Pregnancy

Creating tools and protocols to reduce use, save lives

18-NEU-733-Pediatric-MS-650×450

Pediatric-Onset MS: Study Confirms Some Features, Flags Others as Research Priorities

Notable cohort findings include abnormal saccadic eye movements, use of second-line DMTs

BackPage 69 of 113Next

Advertisement

Ad